Contact

location_on

80B RUE PAUL CAMELLE
33100 BORDEAUX
France

Sebastien MARQUE
Strategic Director

About us

Horiana is a consulting company dedicated to datan analysis in the field of healthcare and life sciences. 

 

Established by a team of seasoned experts, each having over 15 years of experience in Lifesciences, Horiana is at the forefront of providing comprehensive support to its clients. 

 

With a dedicated team of more than 30 experts based in Europe and US, Horiana is well-positioned to assist clients at every phase of their projects. 

 

Our clients spans both private and public/academic healthcare professionals

Business offer

- Expertise and Consulting: Specialized guidance in epidemiology, pharmacoepidemiology, and biostatistics/data science. 

 

  • - Clinical studies methodologies and statistical nalysis (including sample size calculation)

 

- Secondary Databases Studies: Development and analysis of studies using claims data (e.g., SNDS) or cohorts/registries. 

 

- Enriched Studies: Integration of data from diverse sources through multisource studies and linked studies. 

 

- Evidence Synthesis: Conducting External Comparators such as Network Meta-Analysis (NMA) and Matching-Adjusted Indirect Comparison (MAIC). 

 

- Synthetic Control Groups: Implementation of Synthetic Control Groups and External Control Arms. 

 

- Training Programs: training in Statistics & Epidemiology in French and English (Certified QUALIOPI)

Activities

    Categories

    • Service

    Therapeutic applications

    Expertises

    Directory of Antibodies, Recombinant proteins and others
    • Clinical trials
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
    • Clinical biomarkers
    • Predictive biomarkers
    • Treatment efficacy
    • Population stratification
    • Risk/benefit profile
    • Disease progression / follow-up
    • Safety
    • PK/PD features
    • Surrogate markers
    • Disease progression monitoring
    • Companion biomarkers
    • Pharmacology
    • Treatment efficacy
    • Treatment monitoring
    • Toxicity
    • Post-market surveillance
    • Post-Market Surveillance
Français English